There are 2789 resources available
1371TiP - Radiotherapy combined with apatinib and PD-1 inhibitors in patients with brain metastases from non-small cell lung cancer: A single-arm exploratory clinical study
Presenter: Hongwei li
Session: ePoster Display
1375P - SHR-1701, a novel bifunctional anti-PD-L1/TGF-βRII agent, for pretreated recurrent/refractory (r/r) gastric cancer (GC): Data from a first-in-human phase I study
Presenter: Dan Liu
Session: ePoster Display
1453P - Early interdisciplinary supportive care in patients with non-small cell lung cancer: A randomised controlled trial
Presenter: Mengting Chen
Session: ePoster Display
1454P - A prospective trial evaluating the impact of tele-palliative care in cancer patients: Exploring opportunities in adversities
Presenter: Sri Harsha Kombathula
Session: ePoster Display
1379P - Margetuximab (M) with retifanlimab (R) in HER2+, PD-L1+ 1st-line unresectable/metastatic gastroesophageal adenocarcinoma (GEA): MAHOGANY cohort A
Presenter: Daniel Catenacci
Session: ePoster Display
1380P - Phase (Ph) II study of zanidatamab + chemotherapy (chemo) in first-line (1L) HER2 expressing gastroesophageal adenocarcinoma (GEA)
Presenter: Geoffrey Ku
Session: ePoster Display
1381P - Adjuvant nivolumab in resected esophageal or gastroesophageal junction cancer (EC/GEJC) following neoadjuvant chemoradiotherapy (CRT): 14-month follow-up of CheckMate 577
Presenter: Markus Moehler
Session: ePoster Display
1382P - Phase Ib/II open-label, randomised evaluation of second-line atezolizumab (atezo) + linagliptin (lina) vs ramucirumab (ram) + paclitaxel (pac) in MORPHEUS-gastric cancer
Presenter: Jeeyun Lee
Session: ePoster Display